Search Results - Phil Cyr

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Cover Image

    Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients by Daniel C. Malone, Rebecca Dean, Ramesh Arjunji, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Douglas M. Sproule, Douglas E. Feltner, Omar Dabbous

    Published 2019
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and... by Rebecca Dean, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Douglas M. Sproule, Douglas E. Feltner, Thomas Wiesner, Daniel C. Malone, Matthias Bischof, Walter Toro, Omar Dabbous

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: